1-20 of 74
Pallawi Torka
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Large Cells and Ki-67% on Outcomes in Patients with Newly Diagnosed Marginal Zone Lymphoma - Results from a Multicenter Cohort Study

Narendranath Epperla, Natalie S. Grover, Kaitlin Annunzio, Marcus P Watkins, Pallawi Torka, Reem Karmali, Andrea Carolina Anampa-Guzmán, Timothy S. Oh, Heather Reves, Montreh Tavakkoli, Emily Hansinger, Beth Christian, Colin Thomas, Stefan K. Barta, Praveen Ramakrishnan Geethakumari, Nancy L. Bartlett, Geoffrey P. Shouse, Adam J Olszewski
Journal: Blood
Blood (2023) 142 (Supplement 1): 266.
https://doi.org/10.1182/blood-2023-185152
Published: 2023
Journal Articles

Infectious Complications in Patients with Relapsed or Refractory (R/R) Non-Hodgkin's Lymphoma (NHL) Treated with the Anti-CD20xCD3 Bispecific Antibody (BsAb) Mosunetuzumab

Zainab Shahid, Michelle Okwali, Ashlee Joseph, Susan K. Seo, Jennifer Kimberly Lue, Alexander P. Boardman, Philip Caron, Kevin A. David, Zachary D. Epstein-Peterson, Paola Ghione, Paul A. Hamlin, Steven M. Horwitz, Andrew M. Intlekofer, William Johnson, Anita Kumar, Alison Moskowitz, Ariela Noy, Colette Owens, Maria Lia Palomba, Robert Stuver, Pallawi Torka, Santosha A Vardhana, Andrew D. Zelenetz, Gilles Salles, Lorenzo Falchi
Journal: Blood
Blood (2023) 142 (Supplement 1): 4403.
https://doi.org/10.1182/blood-2023-187911
Published: 2023
Journal Articles

Impact of Diagnosis to Treatment Interval on Outcomes in Patients with Newly Diagnosed Marginal Zone Lymphoma - a US Multisite Study

Narendranath Epperla, Kaitlin Annunzio, Geoffrey P. Shouse, Natalie S. Grover, Pallawi Torka, Marcus P Watkins, Andrea Carolina Anampa-Guzmán, Timothy S. Oh, Heather Reves, Montreh Tavakkoli, Emily Hansinger, Beth Christian, Colin Thomas, Stefan K. Barta, Praveen Ramakrishnan Geethakumari, Reem Karmali, Nancy L. Bartlett, Adam J Olszewski
Journal: Blood
Blood (2023) 142 (Supplement 1): 5159.
https://doi.org/10.1182/blood-2023-185205
Published: 2023
Journal Articles

Responses and Outcomes after Second-Line Therapy in Transplant-Eligible Patients with DLBCL Relapse over 1 Year after First-Line Therapy

David A Qualls, Gunjan L. Shah, Roni Shouval, Philip Caron, Kevin A. David, Lorenzo Falchi, Paola Ghione, Paul A. Hamlin, Steven M. Horwitz, Andrew M. Intlekofer, William Johnson, Anita Kumar, Oscar Boutros Lahoud, Jennifer Kimberly Lue, Alison Moskowitz, Ariela Noy, Maria Lia Palomba, Pallawi Torka, Santosha A Vardhana, Andrew D. Zelenetz, Michelle Okwali, Parastoo Bahrami Dahi, Michael Scordo, Richard J. Lin, Miguel-Angel Perales, Gilles Salles
Journal: Blood
Blood (2023) 142 (Supplement 1): 4970.
https://doi.org/10.1182/blood-2023-182733
Published: 2023
Journal Articles

Potent CD8+ T-Cell Proliferation and Effector Differentiation Following Subcutaneous (SC) Mosunetuzumab Administration in Patients with Untreated, High Tumor-Burden Follicular Lymphoma (FL)

Lorenzo Falchi, Ya-Hui Lin, Lauren Melendez, Paola Ghione, Colette Owens, Paul A. Hamlin, Jennifer Kimberly Lue, Zachary D. Epstein-Peterson, Anita Kumar, Maria Lia Palomba, Pallawi Torka, Michelle Okwali, Alexandra Ferreira Lopes, Anastasia Martinova, Lauren Wood, Clare Grieve, Walter Ramos Amador, Andrew D. Zelenetz, Gilles Salles, Santosha A Vardhana
Journal: Blood
Blood (2023) 142 (Supplement 1): 6116.
https://doi.org/10.1182/blood-2023-189638
Published: 2023
Journal Articles

Predicting Toxicities in Older Adults with Non-Hodgkin Lymphoma (NHL) Receiving Systemic Chemotherapy: A Prospective Geriatric Assessment (GA) Study

Pallawi Torka, Esther Drill, Nivetha Ganesan, Mayan Oliveros, Alexander P. Boardman, Philip Caron, Kevin A. David, Zachary D. Epstein-Peterson, Lorenzo Falchi, Paola Ghione, Steven M. Horwitz, Andrew M. Intlekofer, William Johnson, Anita Kumar, Jennifer Kimberly Lue, Alison Moskowitz, Ariela Noy, Colette Owens, Maria Lia Palomba, Robert Stuver, Santosha A Vardhana, Andrew D. Zelenetz, Gilles Salles, Paul A. Hamlin
Journal: Blood
Blood (2023) 142 (Supplement 1): 70.
https://doi.org/10.1182/blood-2023-188143
Published: 2023
Journal Articles

Brentuximab Vedotin-Based Regimens for Older Patients with Newly Diagnosed Classical Hodgkin Lymphoma -Real World Experience

Efrat Luttwak, Nivetha Ganesan, Alexander P. Boardman, Philip Caron, Kevin A. David, Alfredo Rivas-Delgado, Lorenzo Falchi, Paola Ghione, Paul A. Hamlin, Steven M. Horwitz, Andrew M. Intlekofer, William Johnson, Anita Kumar, Jennifer Kimberly Lue, Ariela Noy, Maria Lia Palomba, Robert Stuver, Pallawi Torka, Santosha A Vardhana, Andrew D. Zelenetz, Gilles Salles, Alison Moskowitz
Journal: Blood
Blood (2023) 142 (Supplement 1): 3059.
https://doi.org/10.1182/blood-2023-189617
Published: 2023
Journal Articles

Treatment Patterns and Outcomes for Patients with Classic Hodgkin Lymphoma (cHL) and Cardiomyopathy with Low Ejection Fraction (EF): Real-World Evidence (RWE) from 16 US Academic Centers

Kaitlin Annunzio, Eric McLaughlin, Timothy Voorhees, Lauren Kelly Shea, Nuttavut Sumransub, Ashley Rose, Adam J Olszewski, Neil Bailey, Krish Patel, Tamara K. Moyo, Farrukh T. Awan, Gulrayz Ahmed, Natalie S. Grover, Adam Adika, Erica L Andres, Muhammad Salman Faisal, Beth Christian, Jacob Anna, Steven M. Bair, Nicholas Kendsersky, Colin Thomas, Pallawi Torka, Jakub Svoboda, Jordan S Carter, Mehdi Hamadani, Hayder Saeed, Sanjal H. Desai, Andrew M Evens, Narendranath Epperla
Journal: Blood
Blood (2023) 142 (Supplement 1): 382.
https://doi.org/10.1182/blood-2023-182389
Published: 2023
Journal Articles

Impact of Maintenance Rituximab Following First-Line Systemic Therapy on Outcomes in Patients with Marginal Zone Lymphoma: Real-World Evidence from 10 US Centers

Narendranath Epperla, Kaitlin Annunzio, Geoffrey P. Shouse, Natalie S. Grover, Pallawi Torka, Marcus P Watkins, Andrea Carolina Anampa-Guzmán, Timothy S. Oh, Heather Reves, Montreh Tavakkoli, Emily Hansinger, Beth Christian, Colin Thomas, Stefan K. Barta, Praveen Ramakrishnan Geethakumari, Reem Karmali, Nancy L. Bartlett, Adam J Olszewski
Journal: Blood
Blood (2023) 142 (Supplement 1): 5147.
https://doi.org/10.1182/blood-2023-185182
Published: 2023
Journal Articles

Real-Life Experience with Lenalidomide Plus Anti-CD20 Antibodies for the Treatment of Patients (pts) with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)

Giulio Cassanello, Alfredo Rivas-Delgado, Alejandro Luna De Abia, Magdalena Corona, Efrat Luttwak, Michelle Okwali, Irem Isgor, Pallavi Galera, Alexander P. Boardman, Philip Caron, Kevin A. David, Zachary D. Epstein-Peterson, Paola Ghione, Paul A. Hamlin, Jennifer Kimberly Lue, Steven M. Horwitz, Andrew M. Intlekofer, William Johnson, Anita Kumar, Alison Moskowitz, Ariela Noy, Colette Owens, Maria Lia Palomba, Robert Stuver, Pallawi Torka, Santosha A Vardhana, Andrew D. Zelenetz, Gilles Salles, Lorenzo Falchi
Journal: Blood
Blood (2023) 142 (Supplement 1): 1686.
https://doi.org/10.1182/blood-2023-187783
Published: 2023
Journal Articles

Clinical Characteristics and Outcomes of Limited Stage High Grade B-Cell Lymphoma with MYC/BCL2 and/or BCL6 Rearrangements: A Single Center Experience

Jennifer Kimberly Lue, Efrat Luttwak, Philip Caron, Alexander P. Boardman, Kevin A. David, Alfredo Rivas-Delgado, Zachary D. Epstein-Peterson, Lorenzo Falchi, Paola Ghione, Paul A. Hamlin, Steven M. Horwitz, Andrew M. Intlekofer, William Johnson, Anita Kumar, Alison Moskowitz, Ariela Noy, Maria Lia Palomba, Robert Stuver, Pallawi Torka, Santosha A Vardhana, Andrew D. Zelenetz, Yanming Zhang, Pallavi Galera, Ahmet Dogan, Umut Aypar, Gilles Salles
Journal: Blood
Blood (2023) 142 (Supplement 1): 3129.
https://doi.org/10.1182/blood-2023-173562
Published: 2023
Journal Articles

Final Results of a Phase I/II Trial of Carfilzomib + R-CHOP for Frontline Treatment of Patients with Non-Germinal Center Diffuse Large B-Cell Lymphoma (DLBCL)

Brian T. Hill, Pallawi Torka, Francisco J. Hernandez-Ilizaliturri, Robert M. Dean, Deepa Jagadeesh, Kasra Karamlou, Chieh-Lin Fu, Allison Winter, Ethan Krauspe, Jonathan Zhou, Taylor R. Brooks, Merve Kacar, Ben K. Tomlinson, Brenda W Cooper, Hong Li, Xuefei Jia, Yanwen Chen, Jenna Thomas, Paolo F. Caimi
Journal: Blood
Blood (2023) 142 (Supplement 1): 3087.
https://doi.org/10.1182/blood-2023-173943
Published: 2023
Journal Articles

Allogeneic Stem Cell Transplant and CD30 Directed CART Cell Therapies Are Associated with Improved Survival in Classical Hodgkin Lymphoma Refractory or Intolerant to Brentuximab Vedotin and Anti-PD-1 Therapy: Real World Analysis from 14 U.S. Academic Centers

Timothy Voorhees, Natalie S. Grover, Eric McLaughlin, Jorge A Florindez, Tamara K. Moyo, Heather Reves, Nuttavut Sumransub, Saarang Deshpande, Ashley Rose, Cassandra Duarte, Muhammad Salman Faisal, Showkat Hamid, Suki Subbiah, Sabarish R. Ayyappan, Lauren Kelly Shea, Matthew J Cortese, Krish Patel, Ajay Major, Hayder Saeed, Jakub Svoboda, Sanjal H. Desai, Praveen Ramakrishnan Geethakumari, Pallawi Torka, Narendranath Epperla
Journal: Blood
Blood (2023) 142 (Supplement 1): 900.
https://doi.org/10.1182/blood-2023-182385
Published: 2023
Journal Articles

Ruxolitinib Promotes Clinical Responses in Large Granular Lymphocytic Leukemia Via Suppression of JAK/STAT-Dependent Inflammatory Cascades

Alison Moskowitz, Jahan Rahman, Nivetha Ganesan, Kelly Hannigan, Katie Ksanznak, Hadassah Bitton, Ya-Hui Lin, Theresa Davey, Helen Hancock, Leslie Perez, Tayler Miller, Jamila Brutus, Ahmet Dogan, Mark Blaine Geyer, Eric Jacobsen, Anita Kumar, Jonathan Moreira, Jae H. Park, Meghan C. Thompson, Pallawi Torka, Andrew D. Zelenetz, Santosha A Vardhana, Steven M. Horwitz
Journal: Blood
Blood (2023) 142 (Supplement 1): 183.
https://doi.org/10.1182/blood-2023-181922
Published: 2023
Journal Articles

Nivolumab-AVD Is Better Tolerated and Improves Progression-Free Survival Compared to Bv-AVD in Older Patients (Aged ≥60 Years) with Advanced Stage Hodgkin Lymphoma Enrolled on SWOG S1826

Sarah C. Rutherford, Hongli Li, Alex F. Herrera, Michael Leblanc, Sairah Ahmed, Kelly L. Davison, Carla Casulo, Nancy L. Bartlett, Joseph M Tuscano, Brian Hess, Pallawi Torka, Pankaj Kumar, Ryan W Jacobs, Joo Y Song, Sharon M. Castellino, Brad S. Kahl, John P. Leonard, Sonali M. Smith, Jonathan W. Friedberg, Andrew M Evens
Journal: Blood
Blood (2023) 142 (Supplement 1): 181.
https://doi.org/10.1182/blood-2023-180114
Published: 2023
Journal Articles

Antigen-Specific T-Cell Repertoire Responses Following COVID-19 Vaccination Are Intact in Majority of Patients with B-Cell Lymphoid Malignancies on Active Therapy

Shipra Goel, Elizabeth A. Griffiths, Brahm Segal, Michael Nemeth, Matthew J Cortese, Francisco J. Hernandez-Ilizaliturri, Barbara Banbury, Erika Schumacher, Pallawi Torka, Paola Ghione
Journal: Blood
Blood (2023) 142 (Supplement 1): 5714.
https://doi.org/10.1182/blood-2023-190914
Published: 2023
Journal Articles

Outcomes in Patients with Classical Hodgkin Lymphoma Refractory or Intolerant to Brentuximab Vedotin and Anti-PD-1 Therapy: Real World Analysis from 14 U.S. Academic Centers

Timothy Voorhees, Eric McLaughlin, Pallawi Torka, Jorge A Florindez, Tamara K. Moyo, Heather Reves, Nuttavut Sumransub, Saarang Deshpande, Ashley Rose, Cassandra Duarte, Muhammad Salman Faisal, Showkat Hamid, Suki Subbiah, Sabarish R. Ayyappan, Lauren Kelly Shea, Matthew J Cortese, Krish Patel, Ajay Major, Hayder Saeed, Jakub Svoboda, Sanjal H. Desai, Praveen Ramakrishnan Geethakumari, Natalie S. Grover, Narendranath Epperla
Journal: Blood
Blood (2023) 142 (Supplement 1): 3061.
https://doi.org/10.1182/blood-2023-181056
Published: 2023
Journal Articles

Impact of Early Histological Transformation on Survival in Patients with Follicular Lymphoma

Efrat Luttwak, Annie Qiu, Michelle Okwali, Alfredo Rivas-Delgado, Irem Isgor, Alexander P. Boardman, Philip Caron, Kevin A. David, Lorenzo Falchi, Paola Ghione, Paul A. Hamlin, Steven M. Horwitz, Andrew M. Intlekofer, William Johnson, Anita Kumar, Jennifer Kimberly Lue, Alison Moskowitz, Ariela Noy, Pallavi Galera, M. Lia Palomba, Robert Stuver, Pallawi Torka, Santosha A Vardhana, Andrew D. Zelenetz, Heiko Schoder, Joachim Yahalom, Ahmet Dogan, Gilles Salles
Journal: Blood
Blood (2023) 142 (Supplement 1): 3023.
https://doi.org/10.1182/blood-2023-190325
Published: 2023
Journal Articles

Immune Reconstitution and Infection Patterns Following CAR T-Cell Therapy in Patients with Aggressive Lymphoma

Megan Melody, Narendranath Epperla, Geoffrey P. Shouse, Jason T. Romancik, Tamara K. Moyo, Vaishalee P Kenkre, Thomas Ollila, Lindsey Fitzgerald, Brian Hess, Kevin A. David, Kaitlin Annunzio, Megan Herr, Rahul S. Bhansali, Elyse I Harris, James A Davis, Oluwatobi Odetola, Adam Yuh Lin, Jonathan Moreira, Shuo Ma, Jane N. Winter, Deborah M. Stephens, Alexey Danilov, Nirav N. Shah, Ishan Roy, Stefan K. Barta, Matthew J Cortese, Pallawi Torka, Jonathon B. Cohen, Leo I. Gordon, Reem Karmali
Journal: Blood
Blood (2023) 142 (Supplement 1): 1738.
https://doi.org/10.1182/blood-2023-183011
Published: 2023
Journal Articles

Subcutaneous (SC) Mosunetuzumab (mosun) As First-Line Therapy for Patients (pts) with High Tumor-Burden Follicular Lymphoma (FL): First Results of a Multicenter Phase 2 Study

Lorenzo Falchi, Michelle Okwali, Paola Ghione, Colette Owens, Paul A. Hamlin, Jennifer Kimberly Lue, Zachary D. Epstein-Peterson, Maria Lia Palomba, Anita Kumar, Pallawi Torka, Lori A. Leslie, Alexandra Ferreira Lopes, Anastasia Martinova, Lauren Wood, Clare Grieve, Walter Ramos Amador, Santosha A Vardhana, Andrew D. Zelenetz, Gilles Salles
Journal: Blood
Blood (2023) 142 (Supplement 1): 604.
https://doi.org/10.1182/blood-2023-179906
Published: 2023